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Objectives: We have examined the conditions required to obtain optimum transfection efficiencies for human umbilical 
vein endothelial cells by transduction with a plasmid conferring neomycin resistance. 
Materials and Methods: Preliminary studies examined the effects of electric discharges using the Biorad Gene Pulser on 
endothelial cells. Post-electroporation, there was a significant decrease in cell survival with increasing voltages (100-400 
volts; p = 0.03), capacitances [125-960 microFarads (#F); p = 0.02], number of electric pulses (1-2; p = 0.03) and 
decreasing cell concentrations (p = 0.01). The optimal ceil concentration was 3 × 106 cells/ml. Transfection studies 
utilised the neomycin resistance xpressing plasmid, pTCF; transfectants were selected with the neomycin analogue 
G-148. 
Results: Electro-transfection was optimised with increasing voltages (p = 0.02) and capacitances (p = 0.01) using a 
single pulse. Optimal transfection was obtained using 400 volts with a capacitance of 960~F using a single pulse; the 
median transfection efficiency was 10%. Transduced endothelial cells stably expressed the plasmid for 12 days and at least 
two cell passages. 
Conclusions: The results indicate that endothelial cells can be efficiently transduced by electroporation tostably express 
an introduced gen e. This may have important implications in vascular surgery. 
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Introduction 
Much attention has been directed towards the vas- 
cular endothelium as a potential vehicle for gene 
transfer, aimed at improving the patency of vascular 
prostheses 1-4 and treating gene defects. 2'5-6 The stra- 
tegic location of endothelial cells makes them an 
attractive target for the delivery of gene products with 
paracrine effects. 6 The luminal release of exogenous 
proteins by genetically modified endothelium has 
been proposed as a means of treating thrombosis, 
platelet aggregation, vasoconstriction and smooth 
muscle cell proliferation 7 following arterial recon- 
struction. The introduction of foreign genes into 
endothelial cells using lipofection 2"7, s and retroviral 
transfection 9-~2 has been extensively studied, with 
little attention as yet addressed towards electropora- 
tion as a mechanism of transfection. 
Electroporation is a rapid, simple and efficient 
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method for introducing foreign DNA into mammalian 
cells 13-17 and has been reported to produce higher 
transfection efficiencies than calcium phosphate and 
DEAE-dextran mediated transduction procedures. 18
Electroporation has often been termed electric field 
mediated gene transfer 17 since it uses an electric field 
to make the cell membrane reversibly permeable. 14' 19 
The cell membrane acts as an electrical capacitor 
which is unable (except hrough ion channels) to allow 
current to flow. Following exposure to an electric 
discharge, polarisation of the membrane leads to the 
formation of a potential difference 19 which if large 
enough to exceed a threshold value leads to pore 
development in the cell membrane. The pores may be 
of a sufficient size to allow the transmembrane 
passage of macromolecules such as DNA. 2° The 
reclosing of the permeable cell membrane occurs 
naturally; but if the combination of the magnitude and 
the duration of the electric field exceed a threshold 
value, the cell membrane is irreparably damaged. In 
this stud~ electroporation was performed using a 
gene pulser and a capacitance xtender (Biorad, 
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Hemel Hempstead, U.K.) capable of delivering a high 
voltage of a long duration. The maximum voltage and 
capacitance achievable by this electroporator were 
400V and 960~F respectively. The plasmid pTCF 2~ 
which confers neomycin resistance was used for the 
transfection experiments. 
The most important parameters for successful 
electroporation are the electric field and the time 
constant (duration of the electric discharge). This 
study aimed to optimise electro-transfection of endo- 
thelial cells by determining an electric field and time 
constant that would lead to most efficient gene 
transfer. The electric field is determined by the voltage 
and the distance between the electrodes of the 
electroporetic cuvette; since the latter was always 
constant, the voltage was varied in order to find an 
optimum electric field. Similarly the time constant is 
determined by the capacitance and the resistance of 
the apparatus and as the resistance was always 
constant, he capacitance was varied in order to define 
an optimum time constant. 
It has been proposed that electroporation may 
irreparably damage cells and so the ability of human 
endothelial cells to survive electric pulses was initially 
studied. Based on these initial viability experiments, 
the range of values for the voltage and capacitance 
that could have resulted in electro-transfection were 
then used for the transfection experiments. Prelimi- 
nary studies involved defining an optimum voltage 
for electro-transfection f endothelial cells with a 
constant capacitance. The optimum voltage was then 
constantly maintained and the capacitance varied in 
order to further optimise transfection. The use of 
multiple electric pulses to optimise electro-transfec- 
tion has been advocated and was also studied. 22' 23 
Finally the stability of expression of the plasmid DNA 
was assessed. 
Materials and Methods 
Endothelial cell harvest and culture 
Endothelial cells were procured under sterile condi- 
tions from human umbilical cords within 24 hours of 
delivery using a method modified from Jaffe et al. 24 
Identification of endothelial cells was confirmed by 
their characteristic cobblestone appearance and by 
staining with rabbit anti-human von Willebrand Fac- 
tor antibody (Dakopatts, Glostrup; Denmark) and a 
mouse monoclonal antibody specific for thrombomo- 
dulin (QB-END/40.1 - -  Quantum Biosystems Ltd, 
U.K.). Cells were cultured in T25, 80 and 175 tissue 
culture flasks (Nunclon, Kamstrup; Denmark) with 
Medium 199 (ICN, High Wycornbe, U.K.) containing 
20% fetal calf serum (FCS - -  Sera Lab, Lot 001010, 
U.K.), 100U/ml streptomycin, 100U/ml penicillin 
(NBL, Northumbria, U.K.) at 37°C, 95% air and 5% 
CO2. Endothelial cells were passaged at confluence 
using 0.1% trypsin in 0.02% EDTA (ICN, High 
Wycombe, U.K.) in a ratio of 3:1. All experiments were 
performed using endothelial cells at third passage. 
Electroporetic procedure 
Endothelial cells harvested from culture flasks with 
trypsin/EDTA were washed with MEM + 5% FCS by 
centrifugation at 300g, 4°C for 7 minutes. Viability was 
assessed by trypan blue exclusion (Sigma, Poole, U.K.) 
using a haemocytometer (Weber, Lancing, U.K.). 
Viability was greater than 95% in all cases. Endothelial 
cells at a known concentration were then centrifuged 
(under the same conditions as above) twice; firstly 
with 5 ml of MEM and then with 10 ml of phosphate 
buffered saline (PBS). The final endothelial cell pellet 
was resuspended in 0.8 ml of PBS (the electroporetic 
volume), and transferred to a plastic cuvette (Biorad, 
Hemel Hempstead, U.K.). The cuvette contained two 
aluminium electrodes between which the electric 
discharge passed. Endothelial cells were placed 
between the electrodes and were therefore subjected 
to the electric urrent as required. The capacitance and 
voltage to be used were selected and the plasmid 
DNA added at this stage. Electroporation was per- 
formed using a Biorad electroporator (gene pulser and 
capacitance extender) under a sterile hood (Gelaire 
BSB, U.K.) at 24°C. Following the electroporetic 
procedure, the cells were immediately transferred into 
fresh culture medium and incubated at 37°C, 95% air 
and 5% CO 2. 
Plasmid DNA 
The plasmid pTCF which contains a gene for the 
enzyme conferring neomycin resistance, aminoglyco- 
sidephosphotransferase (AGPT), 21 was purified using 
caesium choride gradient centrifugation. 2s The 
enzyme AGPT is responsible for breaking down G-418 
which inhibits protein synthesis by interfering with 
the codon-anticodon relationship. 26Endothelial cells 
that incorporate pTCF will be able to translate the 
AGPT gene and therefore prevent G-418 from exerting 
its inhibitory actions on protein synthesis. Non- 
Eur J Vasc Endovasc Surg Vol 9, January 1995 
Electroporation of Endothelial Cells 73 
transfected endothelial cells will be subjected to the 
toxicity of G-418 and will therefore die when this 
neomycin analogue is added to their culture 
medium. 
Viability experiments 
In order to investigate the effects of varying the 
strength and duration of electric charge on human 
endothelial cell survival, endothelial cells at passage 
three were subjected to electroporation using different 
voltages and capacitances using the same electro- 
poretic procedure described above. No plasmid DNA 
was utilised during these viability experiments. Fol- 
lowing the electroporetic procedure, endothelial cells 
were placed in a tissue culture flask with complete 
culture medium and incubated at 37°C in a 95% air 
and 5% CO2 atmosphere. After incubation for 24 
hours, the electroporated endothelial cells were 
assessed for cell survival using trypan blue exclusion. 
All experiments were repeated three times. 
(a) The effect of cell concentration on cell survival (%) post- 
electroporation. Endothelial cells at the third subculture 
were harvested from culture flasks using 0.1% trypsin 
in 0.02% EDTA and electroporated at concentrations of 
1, 3 and 5 × 106 cells/ml using a single pulse of 300 
volts with a time constant of 12.6ms (capacitance 
9609Farads). 
(b) The effect of voltage on cell survival (%) post- 
electroporation. The response of endothelial cells to 
voltages of 100, 200, 300 and 400 volts potential 
difference were assessed. Using the optimum cell 
concentration of 3 × 106 cells/ml, defined from the 
previous experiment, endothelial cells were electro- 
porated with the above voltages and a constant 
capacitance of 960~tF yielding a time constant of 
12.6 ms. 
(c) The effect of time constant on ceil survival (%) post- 
electroporation. Differing time constants for the electric 
discharge were achieved by varying the capacitance. 
Endothelial cells at a concentration of 3 × 106 Cells/ml 
were electroporated at 300 volts using capacitances of
125, 250, 500 and 960~F leading to time constants of 
2.5, 4.3, 6.8 and 12.6 ms respectively. 
(d) The effect of multiple lectric pulses on cell survival (%) 
post-electroporation. Endothelial cells at a concentration 
of 3 × 106 cells/ml were electroporated using two 
electric pulses of 300 volts and 960~tF capacitance 
(time constant of 12.6 ms) to determine the ability of 
human endothelial cells to survive a second pulse. The 
gene pulser (Biorad, Hemel Hempstead, U.K.) was 
unable to deliver consecutive pulses automatically 
and subsequently this was performed manually. To 
minimise any inaccuracies due to the time gap 
between pulses the second pulse was delivered 
immediately after the first pulse but a delay of 5 
seconds was still incurred due to recharging of the 
capacitor. 
Transfection studies and G-418 selection 
The viability results were used to set the parameters 
for optimising transfection. Electro-transfection was 
performed at a concentration of 3 × 106 cells/ml with 
voltages between 200-400 volts and capacitances from 
125--9609E Cells were transfected with the test 
plasmid pTCE The selection of transfectants was 
performed using the neomycin analogue G-418 
(GIBCO, Paisley U.K.) at a concentration of 50~g/ml 
which kills all non-transfected ndothelial cells by day 
10 (as previously established in our laboratory). 
Endothelial cells were electroporated at day 0 with 
249g/ml of the plasmid pTCF (a concentration of 
plasmid DNA commonly used in electroporation 
experiments) 15 and the culture medium replaced on 
day 2; on consecutive days thereafter, the existing 
culture medium was replaced with fresh culture 
medium supplemented with 50~tg/ml G-418. Three 
sets of controls were used: endothelial cells alone; 
endothelial cells electroporated with no pTCF and 
finally cells not electroporated but containing pTCF in 
their culture medium. Transfection experiments were 
assessed on day 9 for the number of viable transfected 
cells as determined by trypan blue exclusion. The 
number of transfected endothelial cells was divided 
by the initial cell number to attain a transfection 
efficiency (%). 
(a) The effect of voltage on transfection efficiency of 
endothelial cells. Endothelial cells at a concentration of3 
x 106 cells/ml were exposed to voltages of 200, 300 
and 400 volts with a constant time constant of 12.6 ms 
(960~tF capacitance). The transfection efficiency (TE) 
was calculated on day 9. The voltage transfection 
experiment was repeated four times. 
(b) The effect of time constant on transfection efficiency of 
endothelial cells. Capacitances of 125, 250, 500 and 
960~F with time constants of 2.5, 4.3, 6.8 and 12.6 ms 
respectively and a constant voltage of 400 volts were 
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used to assess the effect of changes in the time 
constant on transduction efficiency. Endothelial cells 
at 3 × 106 cells/ml were electro-transfected using the 
above parameters with the controls as previously 
described. All cells underwent he same selection 
procedure and the TE was calculated on day 9. A 
voltage of 400 volts was chosen because it produced 
the optimum TE as determined from the previous 
experiment. The experiment was again repeated four 
times. 
(c) The effect of multiple electric pulses on transfection 
efficiency of endothelial cells. In order to attempt to 
optimise transfection even further, the optimum 
parameters of 400 volts and 960~F capacitance as 
determined above were used for electroporation but 
this time two electric discharges were passed through 
the endothelial cells. Electro-transfection was also 
attempted with two electric pulses at 200 and 300 volts 
at 960~F. All experiments were repeated four times. 
loss of or inactivation of the gene for AGPT was 
assumed to have occurred. 
Statistics 
Statistical analysis of results was performed using the 
Minitab Release 8.1 statistical programme (Minitab 
Inc, Pennysylvania, U.S.A.) on a Macintosh LC per- 
sonal computer (Apple Computer Inc, California, 
U.S.A.). The results are presented as median values 
with 95% confidence intervals where appropriate. The 
statistical tests used were the Mann-Whitney U Test 
and linear regression analysis. 
For the data regarding the stability of expression 
of the plasmid DNA, significance was assessed by 
calculating the areas under the curves, which repre- 
sented the total number of cells over the period of 
study and performing Mann-Whitney U Test analyses 
on the data. 
Stability of expression of the plasmid pTCF 
In order to determine whether the introduced plasmid 
pTCF was being stably expressed, endothelial cells 
electro-transfected with pTCF and then selected with 
50~g/ml G-418 for 9 days were plated at a concentra- 
tion of 5 × 104 cells/ml per well in a 24 well plate 
(Nunclon, Kamstrup, Denmark). The transfected 
endothelial cells were cultured with or without 
50~g/ml G-418. Transfected cells grown in culture 
medium without G-418 acted as a control together 
with non-electroporated endothelial cells groWn with 
or without 50~g/ml G-418. Each day, the endothelial 
cells in 4 wells were harvested and the viable cell 
concentration determined by trypan blue exclusion. If 
the plasmid pTCF was stably expressed, transfected 
cells grown with 50~tg/ml G-418 would survive due to 
expression of AGPT, whereas non-transfected endo- 
thelial cells would fail to survive. 
The number of cell passages that the introduced 
plasmid pTCF was expressed was also studied. 
Transduced endothelial cells were grown on culture 
medium in T25 tissue culture flasks with or without 
50~g/ml G-418 and passaged to confluence. Control 
non-electroporated ndothelial cells were also either 
exposed to G-418 or grown with culture medium 
alone. The longer the expression of the plasmid, the 
more passages but the transfected cells would survive 
when grown with culture medium and 50~g/ml 
G-418. When transfected cells grown with G-418 died 
but transfected cells grown without G-418 survived, 
Results 
Viability studies 
(a) The effect of cell concentration on cell survival post- 
electroporation. This experiment demonstrated that 
there was a significant increase in cell survival (%) 
with increasing cell concentrations (Fig. 1) (r 2 = 
82.8%, p = 0.001; linear regression analysis). From 
these results (Fig. 1), it was concluded that transfect- 
ing with 3 × 106 cells/ml would yield optimum 
transfection efficiencies as there was no significant 
difference in the cell survival (%) when electroporat- 
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Fig. 1. Graph showing the effect of varying cell concentrations on 
cell survival (%) after electroporation. I dividual points are plotted 
with the best fit linear regression line. 
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ml (W = 6.5, p = 0.13; Mann-Whitney U Test). In 
transfection studies a cell concentration of 3 X 106 
cells/ml was utilised as this represented a balance 
between maximum cell survival and the quantity of 
cells required for individual experiments. 
(b) The effect of voltage on cell survival post-electropora- 
tion. As the transfection voltage increased from 
100-400 volts, there  was a significant decrease in 
endothelial cell survival (%) (Fig. 2; r 2 = 92.4%, p = 
0.03. Linear regression analysis). 
(c) The effect of time constant on cell survival post- 
electroporation~ Increasing capacitances and thus time 
constants led to a significant decrease in cell survival 
post-electroporation (Fig. 3; r 2 = 82.8%, p = 0.02. 
Linear regression analysis). The experiment showed 
that endothelial cells could survive voltages with 
capacitances up to 960~F. 
(d) The effect of multiple electric pulses on cell survival 
post-electroporation. Pulsing endothelial cells twice as 
compared to once resulted in a decrease in cell 
survival (Fig. 4; W = 26, p -- 0.03. Mann-Whitney U
Test). This result demonstrated that endothelial cells 
were more sensitive to the introduction of a second 
pulse as compared with only one pulse. Nevertheless, 
endothelial cells were able to survive a second pulse 
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Fig. 2. Graph showing the effect of voltage on endothelial cell 
survival (%) post-electroporation. The data is presented as a linear 
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Fig. 3. Graph demonstrating the effect of varying capacitances and 
thus time constants on endothelial cell survival following electro- 
poration. Individual points are plotted with the best fit linear 
regression line. 
Transfection studies 
(a) Morphology of transfected endothelial cells. Transfected 
endothelial cells displayed the characteristic cobble- 
stone pattern of endothelial cells under phase contrast 
microscopy. The transfected cells formed close colo- 
nies of cells. 
(b) The effect of voltage on transfection efficiency. As the 
voltage was increased, electro-transfection became 
optimised (Fig. 5; r 2 --- 60.2%, p = 0.002. Linear 
regression analysis). Transfection was optimal at 400 
volts with a median TE of 10%. Comparable TE's were 
obtained using 300 volts but at 200 volts the TE was 


















Fig. 4. Graph showing the effect of one or two electric pulses on 
endothelial cells. The median cell survival at one and two pulses is 
shown. 
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Fig. 5. Graph displaying the effect of changes in voltage on the 
transfection efficiences of endothelial cells. Individual points are 
plotted with the best fit linear regression line. A voltage of 400 volts 
produced the optimum transfection efficiency with a median value 
of 10%. 
960~tF capacitance to allow voltage to be the only 
variable. 
(c) The effect of capacitance on transfection efficiency. 
Decreasing capacitances (time constants) produced a 
significant reduction in TE (Fig. 6; r 2 = 53.7%, p = 
0.001. Linear regression analysis). Optimal transfec- 
tion efficiencies were obtained using capacitances of
960~F (Fig. 6). 
(d) The effect of multiple electric pulses on transfection 
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Fig. 6. Graph showing the transfection efficiencies of endothelial 
cells wittl varying capacitances up to 960~tFarads. Optimum 
transfection was gained using 960~Farads. The data is plotted as a 
linear regression showing the line of best fit. 
single pulse at 400 volts and 960~F, transfection was 
attempted with the same parameters but with two 
pulses. At 400 volts double pulse, the endothelial cells 
were unable to survive the electroporation; 24 hours 
after the procedure all endothelial cells had died. With 
double pulsing at 300 volts there was initial cell 
survival but after 72 hours the endothelial cells died. 
Finally the double pulse was attempted at 200 volts, 
the endothelial cells survived the G-418 supplement 
on days 4 and 6 but by day 7, the cells had died and no 
transfectants remained. 
(e) The stability of expression of the plasmid. Endothelial 
cells transfected with the plasmid pTCF and grown 
with 50~g/ml G-418 demonstrated no significant 
difference in reproductive capacity compared with 
transfected cells cultured without G-418 up to day 12 
(Fig. 7; W = 103.5, p = 0.94. Mann-Whitney U Test). 
After 12 days, there was a decrease in cell survival for 
the G418 grown transduced cells whereas the trans- 
duced cells grown without G-418 continued to retain 
their viability. 
Non-transfected control endothelial cells grown 
with 50~g/ml G-418 failed to survive after day 10 but 
displayed similar proliferative rates to the transfected 
cells up to day 5 (Fig. 7). Control endothelial cells 
grown without G-418 maintained viability past 20 
days. There was no significant difference in the 
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Fig. 7. Graph showing the stability of expression of the plasmid 
pTCF after electro-transfection of endothelial cells. The transduced 
endothelial cells were grown on either culture medium alone 
(control) or with culture medium supplemented with 50~tg/ml 
G-418. A further control of non-electroporated ndothelial cells 
grown with culture medium and 50~g/ml G-418 was also used. The 
points are plotted as median values with standard error bars. ([3) 
transfected cells 50~g/ml; (o) transfected cells; (B) control cells 
50~g/ml. 
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without G-418 up to day 12 (W = 103.5, p = 0.94; 
Mann-Whitney U Test). This result shows that the 
introduced plasmid pTCF was stably expressed for up 
to 12 days. 
The number of cell passages that the plasmid 
pTCF was expressed was assessed by growing trans- 
fected cells on culture medium containing 50~g/ml 
G-418. At confluence, the transfected cells were pass- 
aged and allowed to proliferate to confluence again. 
Transfected endothelial cells grown with culture 
medium supplemented with 50~g/ml G-418 were able 
to survive the first passage and rapidly repopulated 
the tissue culture flask at passage 1. At passage 2, the 
transfected endothelial cells again survived and grew 
to confluence but by passage 3, the transfected cells 
grown with G-418 gradually slowed in growth and 
eventually died. Since transfected cells grown without 
G-418 survived past passage 3, it was concluded that 
the introduced plasmid had been lost by this passage. 
Control untransfected endothelial cells grown with 
50-g/ml G-418 were unable to survive the first passage 
and became non-viable without attaining confluence. 
Discussion 
Electroporation has been used to deliver foreign genes 
to endothelial cells. 2~23 This study aimed to optimise 
electro-transfection by investigating the factors most 
essential for gene transfer and manipulating those 
factors to achieve optimisation of transduction. Viabil- 
ity experiments were initially performed to identify 
the critical parameters and the transfection studies 
utilised the viability results to optimise transduction. 
The most crucial parameters for electro-transfec- 
tion are the cell concentration, electric field, time 
constant and the number of electric pulses. The effects 
of changes in these parameters on endothelial cell 
survival post-electroporation were investigated. Prior 
to transfecting endothelial cells with the plasmid 
pTCF, it was necessary to determine an optimum cell 
concentration that would result in an acceptable cell 
survival (%) post-electroporation. Since cell types 
ri , 19 differ in their ability to respond to an elect c pulse, 
it follows that a particularly susceptible cell type may 
benefit from increased cell numbers prior to electro- 
poration. The results (Fig. 1) showed a significant 
increase in cell survival with increasing cell concentra- 
tions up to 3 × 106 cells/ml. There was no significant 
difference in the cell survival when electroporating 
with cell concentrations of 3 and 5 × 106 cells/ml. Chu 
et al. ~5 attempted electro-transfection into human fetal 
lung fibroblasts with cell concentrations ranging from 
106 to 107 cells/ml and reported similar TE regardless 
of the initial cell density. The results from this viability 
experiment showed that transduction would be opti- 
mal when electroporating with 3 × 106 cells/ml and 
that electroporating with I × 106 cells/ml would yield 
too few transfectants. 
As the voltage increased the cell survival sig- 
nificantly decreased (Fig. 2). This has been reported 19 
and may be explained by the principle that when high 
voltages are passed through cells, the potential differ- 
ence created exceeds the critical threshold for irrepara- 
ble damage of the cells. At lower voltages, much fewer 
cells are irreparably damaged and consequentl~ cell 
survival is significantly higher. The voltage viability 
experiments demonstrated that endothelial cells were 
capable of maintaining viability when exposed to 
voltages as high as 400 volts (maximum obtainable on 
gene pulser) and for that reason the transfection 
studies used voltages up to 400 volts. 
As the time constant increased, cell survival 
significantly decreased (Fig. 3). This shows that 
capacitance is an important factor for electroporation. 
Longer time constants lead to wider pores and longer 
duration of the pores and although this increases the 
possibility of DNA entering, it simultaneously 
decreases the cell survival as shown by the viability 
results. 
The increased cell loss using two electric pulses as 
compared with one (Fig. 4) stems from the principle 
that the longer the pulse, the stronger the electric field 
and the more energy that is dissipated across the 
sample. Increased energy leads to an increase in cell 
death since many more cells are irreparably damaged. 
Although the double pulse viability experiment 
showed it was a feasible option, it was found that long 
term viability was severely impaired. 
More extensive membrane dissociation and pore 
development ensued with increased voltage but 
antagonisticall~ greater cell loss occurred (Fig. 2). The 
increased pore formation will result in increased 
transfection but the reduction in cell viability leads to 
a decrease in the number of transfectants. Optimising 
transfection ecessitates finding a voltage that pro- 
duces the largest number of viable and reversibly 
permeable cells. Electro-transfection was optimal at 
400 volts. Since this value produced the greatest cell 
loss, it would be assumed that it would not produce 
optimal TE. The fact that 400 volts was optimal 
showed that its effect on DNA entry must have been 
potent enough to combat he large reduction in cell 
viability. Electroporating with 200 and 300 volts which 
both produced higher cell survivals yielded lower 
transfectants and therefore it can be assumed that their 
effect on DNA entry was much less than 400 volts. 
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As the capacitance and time constant increased, 
TE was optimised. Wider pores and longer durations 
of the pores occur with increasing time constants and 
therefore DNA, present in the buffer medium has a 
much larger chance of entering the intracellular 
compartment. At lower capacitances the pores are 
smaller and open for a shorter period and therefore TE 
was not optimised even though the cell survival was 
higher (Fig. 3) as compared with the larger capaci- 
tances. Transfecting endothelial cells using two pulses 
at 960~tF and 200, 300 and 400 volts was unsuccessful. 
The overall conclusion from the double pulse experi- 
ments must suggest hat the use of multiple electric 
pulses is less efficient than single pulse electro- 
transfection. This has also been reported with mam- 
malian cells. 15 Although multiple pulse electroporesis 
increases the number of pores, it simultaneously 
increases the energy dissipation across the cells and 
leads to a situation where the number of irreparably 
damaged cells far outweighs the number of viable and 
reversibly permeable cells. Multiple pulse electro- 
transfection of endothelial cells has been success- 
ful, 22-23 different electroporators were used in these 
studies and this most probably accounts for the 
difference in results. The machine used in this study 
was not able to deliver the second pulse automatically 
and therefore the second pulse had to delivered by 
hand; this may account for the failure to electroporate 
when using two pulses. 
If electro-transfected endothelial cells are to be 
used for seeding of vascular grafts, it is essential that 
they stably express the introduced gene, Transient 
expression lasting only 48 hours would not permit 
clinically effective quantities of the introduced gene to 
be expressed. Endothelia ! cells transfected with the 
plasmid pTCF stably expressed the AGPT gene for 
neomycin resistance for 12 days and at least two 
passages. It was concluded that electroporation is an 
efficient method for introducing foreign DNA into 
endothelial cells and the optimal parameters for DNA 
entry have been identified. Endothelial cells that have 
been electro-transfected with the gene for tissue 
plasminogen activator (t-PA) may be used to treat 
thrombosis occurring after balloon angioplasty and 
endarterectomy. A gene such as t-PA is only required 
initially to prevent early thrombosis, overexpression 
of t-PA may lead to degradation of the basement 
membrane and the initiation of smooth muscle cell 
proliferation leading to intimal hyperplasia, 27 a cause 
of intermediate and late graft failure. The intermediate 
length of expression of the introduced plasmid 
obtained by the electroporetic conditions outlined in 
this study may therefore be optimal for gene 
transfer. 
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